OpenURL Connection Search

Select item for more details and to access through your institution.

Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.
Published in:
PLoS Pathogens, 2021, v. 17, n. 2, p. 1, doi. 10.1371/journal.ppat.1009165
By:
- Mor, Michael;
- Werbner, Michal;
- Alter, Joel;
- Safra, Modi;
- Chomsky, Elad;
- Lee, Jamie C.;
- Hada-Neeman, Smadar;
- Polonsky, Ksenia;
- Nowell, Cameron J.;
- Clark, Alex E.;
- Roitburd-Berman, Anna;
- Ben-Shalom, Noam;
- Navon, Michal;
- Rafael, Dor;
- Sharim, Hila;
- Kiner, Evgeny;
- Griffis, Eric R.;
- Gershoni, Jonathan M.;
- Kobiler, Oren;
- Leibel, Sandra Lawrynowicz
Publication type:
Article
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy (Adv. Sci. 40/2024).
Published in:
Advanced Science, 2024, v. 11, n. 40, p. 1, doi. 10.1002/advs.202470245
By:
- Acúrcio, Rita C.;
- Kleiner, Ron;
- Vaskovich‐Koubi, Daniella;
- Carreira, Bárbara;
- Liubomirski, Yulia;
- Palma, Carolina;
- Yeheskel, Adva;
- Yeini, Eilam;
- Viana, Ana S.;
- Ferreira, Vera;
- Araújo, Carlos;
- Mor, Michael;
- Freund, Natalia T.;
- Bacharach, Eran;
- Gonçalves, João;
- Toister‐Achituv, Mira;
- Fabregue, Manon;
- Matthieu, Solene;
- Guerry, Capucine;
- Zarubica, Ana
Publication type:
Article
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy.
Published in:
Advanced Science, 2024, v. 11, n. 40, p. 1, doi. 10.1002/advs.202404159
By:
- Acúrcio, Rita C.;
- Kleiner, Ron;
- Vaskovich‐Koubi, Daniella;
- Carreira, Bárbara;
- Liubomirski, Yulia;
- Palma, Carolina;
- Yeheskel, Adva;
- Yeini, Eilam;
- Viana, Ana S.;
- Ferreira, Vera;
- Araújo, Carlos;
- Mor, Michael;
- Freund, Natalia T.;
- Bacharach, Eran;
- Gonçalves, João;
- Toister‐Achituv, Mira;
- Fabregue, Manon;
- Matthieu, Solene;
- Guerry, Capucine;
- Zarubica, Ana
Publication type:
Article
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.
Published in:
Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03739-5
By:
- Li, Ruofan;
- Mor, Michael;
- Ma, Bingting;
- Clark, Alex E.;
- Alter, Joel;
- Werbner, Michal;
- Lee, Jamie Casey;
- Leibel, Sandra L.;
- Carlin, Aaron F.;
- Dessau, Moshe;
- Gal-Tanamy, Meital;
- Croker, Ben A.;
- Xiang, Ye;
- Freund, Natalia T.
Publication type:
Article
Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-20930-0
By:
- Watson, Avia;
- Li, Hao;
- Ma, Bingting;
- Weiss, Ronen;
- Bendayan, Daniele;
- Abramovitz, Lilach;
- Ben-Shalom, Noam;
- Mor, Michael;
- Pinko, Erica;
- Bar Oz, Michal;
- Wang, Zhenqi;
- Du, Fengjiao;
- Lu, Yu;
- Rybniker, Jan;
- Dahan, Rony;
- Huang, Hairong;
- Barkan, Daniel;
- Xiang, Ye;
- Javid, Babak;
- Freund, Natalia T.
Publication type:
Article

Found: 5

Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.

Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy (Adv. Sci. 40/2024).

Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy.

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.

Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis.